Withdrawn before it began
Evaluation of the XACT Robotic System for Image-guided Percutaneous Lung Procedures
NCT04612985 · Xact Robotics Ltd. · Updated 3 Nov 2020
- What is being tested
- XACT Robotic System
- For
- CT-guided Minimally Invasive Procedures e.g. Biopsies
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. The full rules are on the registry page.
- Where
- United States, Israel (2 sites)
- When
- Starts or started Sept 2018, ends Dec 2019. Registered 3 Nov 2020.
- Results
- None posted yet.
In the researchers' words
This is a prospective, single arm study, to evaluate the safety, effectiveness and usability of the XACT device. Subjects undergoing CT-guided, minimally invasive percutaneous lung procedures in the interventional radiology suite. eg. core, biopsy, will participate in the study. System and clinical accuracy will be the primary efficacy endpoint. Usability and safety will also be evaluated.
Sites
- Lahey Hospital and Medical CenterBurlington, Massachusetts, United States
- Hadassah Medical CenterJerusalem, Israel